>
Federal Reserve's 'Doomsday Book' Reveals Vast Power Claimed by Central Bank
How to Make Your Own Seed Starting Mix and Start Seedlings
Age Verification is a Trick with a Different Intent than What You Think
Crazy Day on Coinbase News, but Charts Still Bullish!
Scientists Close To Controlling All Genetic Material On Earth
Doodle to reality: World's 1st nuclear fusion-powered electric propulsion drive
Phase-change concrete melts snow and ice without salt or shovels
You Won't Want To Miss THIS During The Total Solar Eclipse (3D Eclipse Timeline And Viewing Tips
China Room Temperature Superconductor Researcher Had Experiments to Refute Critics
5 video games we wanna smell, now that it's kinda possible with GameScent
Unpowered cargo gliders on tow ropes promise 65% cheaper air freight
Wyoming A Finalist For Factory To Build Portable Micro-Nuclear Plants
High-Speed Railway Progresses Towards 200-mph Dallas-Houston Line
27 Ft-tall 3D-printed Structure Built by New Robot | ICON's Multi-Story Robotic Construction Sys
The Oisin technology is highly adaptable, and can be programmed to kill any class of cell that has some distinct internal marker in the form of high levels of expression of a specific protein. The founders started with senescent cells based on the p16 marker, but as this latest interview with Gary Hudson makes clear, have expanded their efforts to effectively target cancer with p53, and beyond that they are really only limited by time, funding, and a good map of the internal biochemistry of the target cell type. The sky is the limit in the long term: any type of cell that is undesirable should have some distinctive chemistry that can be attacked, and there are many possible targets.
This update is from FightAging.org. The writer of Fightaging is also invested in the Oisin company.